Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2
- DOI
- 10.1016/j.lanhl.2026.100894
- Published
- 2026-08
- Container
- The Lancet Healthy Longevity
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanhl.2026.100894,
title = {Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2},
author = {Caroline Espersen and Niklas D Johansen and Daniel Modin and Kira H Janstrup and Matthew M Loiacono and Rebecca C Harris and Youjun Huang and Carsten S Larsen and Lykke Larsen and Lothar Wiese and Michael Dalager-Pedersen and Brian L Claggett and Katja V Bartholdy and Katrine F Bernholm and Julie I-M H Borchsenius and Filip S Davidovski and Lise W Davodian and Maria Dons and Lisa S Duus and Frederik H Fussing and Anne Marie R Jensen and Nino E Landler and Adam C F Langhoff and Mats C H Lassen and Anne B Nielsen and Camilla I Ottosen and Morten Sengeløv and Kristoffer G Skaarup and Scott D Solomon and Martin J Landray and Gunnar H Gislason and Lars Køber and Pradeesh Sivapalan and Cyril J-M Martel and Jens U S Jensen and Kazumasa Harada and Gaetan Gavazzi and Tor Biering-Sørensen},
year = {2026},
journal = {The Lancet Healthy Longevity},
doi = {10.1016/j.lanhl.2026.100894},
url = {https://doi.org/10.1016/j.lanhl.2026.100894}
}RIS
TY - JOUR TI - Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2 AU - Caroline Espersen AU - Niklas D Johansen AU - Daniel Modin AU - Kira H Janstrup AU - Matthew M Loiacono AU - Rebecca C Harris AU - Youjun Huang AU - Carsten S Larsen AU - Lykke Larsen AU - Lothar Wiese AU - Michael Dalager-Pedersen AU - Brian L Claggett AU - Katja V Bartholdy AU - Katrine F Bernholm AU - Julie I-M H Borchsenius AU - Filip S Davidovski AU - Lise W Davodian AU - Maria Dons AU - Lisa S Duus AU - Frederik H Fussing AU - Anne Marie R Jensen AU - Nino E Landler AU - Adam C F Langhoff AU - Mats C H Lassen AU - Anne B Nielsen AU - Camilla I Ottosen AU - Morten Sengeløv AU - Kristoffer G Skaarup AU - Scott D Solomon AU - Martin J Landray AU - Gunnar H Gislason AU - Lars Køber AU - Pradeesh Sivapalan AU - Cyril J-M Martel AU - Jens U S Jensen AU - Kazumasa Harada AU - Gaetan Gavazzi AU - Tor Biering-Sørensen PY - 2026 JO - The Lancet Healthy Longevity DO - 10.1016/j.lanhl.2026.100894 UR - https://doi.org/10.1016/j.lanhl.2026.100894 ER -
APA
Espersen, C., Johansen, N. D., Modin, D., Janstrup, K. H., Loiacono, M. M., Harris, R. C., Huang, Y., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Bartholdy, K. V., Bernholm, K. F., Borchsenius, J. I. H., Davidovski, F. S., Davodian, L. W., Dons, M., Duus, L. S., Fussing, F. H., Jensen, A. M. R., Landler, N. E., Langhoff, A. C. F., Lassen, M. C. H., Nielsen, A. B., Ottosen, C. I., Sengeløv, M., Skaarup, K. G., Solomon, S. D., Landray, M. J., Gislason, G. H., Køber, L., Sivapalan, P., Martel, C. J., Jensen, J. U. S., Harada, K., Gavazzi, G., & Biering-Sørensen, T. (2026). Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2. The Lancet Healthy Longevity. https://doi.org/10.1016/j.lanhl.2026.100894
Source records
- crossref · retrieved 2026-09-26T05:42:07.319Z